Immunocore’s (IMCR) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Immunocore (NASDAQ:IMCR – Free Report) in a research note published on Wednesday,Benzinga reports. The firm currently has a $100.00 price target on the stock. Other equities analysts have also recently issued reports about the stock. Morgan Stanley restated an “equal weight” rating and set a $35.00 […]
HC Wainwright restated their buy rating on shares of Immunocore (NASDAQ:IMCR – Free Report) in a research note published on Wednesday,Benzinga reports. The firm currently has a $100.00 price target on the stock. Other equities analysts have also recently issued reports about the stock. Morgan Stanley restated an “equal weight” rating and set a $35.00 […]
